Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04572074 · ClinicalTrials.gov registry record · NA
Virtual Reality for Cancer Pain Management
A NA study of Cancer and Cancer Pain, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT04572074: Completed NA study of Cancer and Cancer Pain, sponsored by Medstar Health Research Institute.
NCT04572074 is a NA study of Cancer and Cancer Pain that has completed, run by Medstar Health Research Institute. The registered enrollment target is 128 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04572074, a NA study of Cancer and Cancer Pain, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research project is to evaluate the impact of virtual reality therapy on mitigating cancer pain in hospitalized patients with cancer and compare this impact to that of 2-dimensional guided imagery distraction therapy. The purpose is also to evaluate acceptability of and satisfaction with virtual reality therapy and to examine racial and cultural preferences related to virtual reality and guided imagery thematic content.
Primary Outcome
Likert scale 0 (no pain) to 10 (worst pain)
Conditions Studied
Interventions
- OTHER Guided imagery
- OTHER Virtual reality
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT04572074 record still lists
NCT04572074 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Guided imagery is the first listed.
NCT04572074 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04572074 about?
NCT04572074 is a clinical study titled "Virtual Reality for Cancer Pain Management". The purpose of this research project is to evaluate the impact of virtual reality therapy on mitigating cancer pain in hospitalized patients with cancer and compare this impact to that of 2-dimensional guided imagery distraction therapy. The purpose is also to evaluate acceptability of and satisfact...
What is the current status of trial NCT04572074?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2020-02-01. Estimated completion is 2022-09-30.
What conditions does trial NCT04572074 study?
This clinical trial studies the following conditions: Cancer, Cancer Pain.
What interventions are being tested in trial NCT04572074?
The interventions under investigation include: Guided imagery (OTHER), Virtual reality (OTHER).
Who is sponsoring clinical trial NCT04572074?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04572074 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04572074's enrollment target sits among peer trials
128 281st of 615 higher than 335 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI